Herbal medicines in the treatment of psychiatric disorders: 10-year updated review

Abstract

This paper provides a 10-year update of the 2007 systematic review of herbal medicines studied in a broad range of psychiatric disorders, including depression, anxiety, obsessive-compulsive, seasonal affective, bipolar, psychotic, phobic, somatoform, and attention-deficit hyperactivity disorders. Ovid Medline, PubMed, and the Cochrane Library were searched for herbal medicines with both pharmacological and clinical evidence of psychotropic activity. This updated review now covers clinical trial evidence for 24 herbal medicines in 11 psychiatric disorders. High-quality evidence was found to exist for the use of Piper methysticum (Kava), Passiflora spp. (passionflower) and Galphimia glauca (ga..

View full abstract

Grants

Funding Acknowledgements

J.S. has received either presentation honoraria, travel support, clinical trial grants, book royalties, or independent consultancy payments from Integria Healthcare & MediHerb, Pfizer, Scius Health, Key Pharmaceuticals, Taki Mai, Bioceuticals & Blackmores, Soho-Flordis, Healthworld, HealthEd, HealthMasters, Elsevier, Chaminade University, International Society for Affective Disorders, Complementary Medicines Australia, Terry White Chemists, ANS, Society for Medicinal Plant and Natural Product Research, Sanofi-Aventis, Omega-3 Centre, the National Health and Medical Research Council, and CR Roper Fellowship.

Citation metrics

Keywords

SHOWING 1-10 OF 191 REFERENCES

Plant-Based Medicines for Anxiety Disorders, Part 1

  • J. SarrisE. McIntyreD. Camfield
  • Biology

    CNS Drugs

  • 2013

Common mechanisms of action for the majority of botanicals reviewed primarily involve GABA, either via direct receptor binding or ionic channel or cell membrane modulation; GABA transaminase or glutamic acid decarboxylase inhibition; a range of monoaminergic effects; and potential cannabinoid receptor modulation.

Herbal remedies in psychiatric practice.

  • A. WongM. SmithH. Boon
  • Medicine, Psychology

    Archives of general psychiatry

  • 1998

In many cases the quantity and quality of data were insufficient to make definitive conclusions about efficacy or safety, but there was good evidence for the efficacy of St John's wort for the treatment of depression and for ginkgo in the Treatment of memory impairment caused by dementia.

Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies

  • Adrian L. Lopresti
  • Psychology, Biology

    Journal of psychopharmacology

  • 2017

In this systematic review, in vitro, animal, and human studies investigating the potential of curcumin as a treatment for neuropsychiatric disorders such as major depressive disorder, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), bipolar disorder, psychotic disorders, and autism are reviewed, and directions for future research are proposed.

Ashwagandha for anxiety disorders

  • C. Andrade
  • Psychology, Medicine

    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

  • 2009

Ashwagandha (ASW) appeared to have several of the advantages but none of the disadvantages of conventional anxiolytic drugs such as antidepressants and the benzodiazepines.

Review

Herbal medicines in the treatment of psychiatric disorders: a systematic review

Jerome Sarris. Phytother Res. 2007 Aug.

Abstract

This paper reports a critical review of 27 herbal medicines and formulas in treating a broad range of psychiatric disorders (in addition to anxiety and depression), including obsessive-compulsive, seasonal affective, bipolar depressive, psychotic, phobic and somatoform disorders. Ovid Medline, Pubmed and the Cochrane Library were searched for pharmacological and clinical evidence of herbal medicines with psychotropic activity. A forward search of later citations was also conducted. Whilst substantial high-quality evidence exists for the use of kava and St John's wort in the treatment of anxiety and depression respectively, currently there is insufficient robust clinical evidence for the use of many other herbal medicines in psychiatric disorders. Phytotherapies which potentially have significant use in psychiatry, and urgently require more research are Rhodiola rosea (roseroot) and Crocus sativus (saffron) for depression; Passiflora incarnata (passionflower), Scutellaria lateriflora (scullcap) and Zizyphus jujuba (sour date) for anxiety disorders; and Piper methysticum (kava) for phobic, panic and obsessive-compulsive disorders. While depression and anxiety are commonly researched, the efficacy of herbal medicines in other mental disorders requires attention. The review addresses current issues in herbal psychotherapy: herbal safety, future areas of application, the relationship of herbal medicine with pharmaceuticals and the potential prescriptive integration of phytomedicines with synthetic psychotropic medicines. Particular attention is given to clinical and safety issues with St John's wort and kava.

(c) 2007 John Wiley & Sons, Ltd.

Similar articles

  • Herbal medicines in the treatment of psychiatric disorders: 10-year updated review.

    Sarris J. Sarris J. Phytother Res. 2018 Jul;32(7):1147-1162. doi: 10.1002/ptr.6055. Epub 2018 Mar 25. Phytother Res. 2018. PMID: 29575228 Review.

  • Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.

    Sarris J, Kavanagh DJ. Sarris J, et al. J Altern Complement Med. 2009 Aug;15(8):827-36. doi: 10.1089/acm.2009.0066. J Altern Complement Med. 2009. PMID: 19614563 Review.

  • Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence.

    Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Sarris J, et al. Eur Neuropsychopharmacol. 2011 Dec;21(12):841-60. doi: 10.1016/j.euroneuro.2011.04.002. Epub 2011 May 23. Eur Neuropsychopharmacol. 2011. PMID: 21601431 Review.

  • Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

    Sarris J, McIntyre E, Camfield DA. Sarris J, et al. CNS Drugs. 2013 Apr;27(4):301-19. doi: 10.1007/s40263-013-0059-9. CNS Drugs. 2013. PMID: 23653088 Review.

  • Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review.

    Dwyer AV, Whitten DL, Hawrelak JA. Dwyer AV, et al. Altern Med Rev. 2011 Mar;16(1):40-9. Altern Med Rev. 2011. PMID: 21438645 Review.

Cited by

  • The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders.

    Shamabadi A, Hasanzadeh A, Akhondzadeh S. Shamabadi A, et al. Avicenna J Phytomed. 2022 Sep-Oct;12(5):475-488. doi: 10.22038/AJP.2021.19300. Avicenna J Phytomed. 2022. PMID: 36249453 Free PMC article. Review.

  • Fatty acid amide hydrolase inhibition and N-arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants.

    Zada W, VanRyzin JW, Perez-Pouchoulen M, Baglot SL, Hill MN, Abbas G, Clark SM, Rashid U, McCarthy MM, Mannan A. Zada W, et al. Pharmacol Res Perspect. 2022 Oct;10(5):e00999. doi: 10.1002/prp2.999. Pharmacol Res Perspect. 2022. PMID: 36029006 Free PMC article.

  • Hyperelatosides A-E, biphenyl ether glycosides from Hypericum elatoides, with neurotrophic activity.

    Yan XT, An Z, Tang D, Peng GR, Cao CY, Xu YZ, Li CH, Liu PL, Jiang ZM, Gao JM. Yan XT, et al. RSC Adv. 2018 Jul 25;8(47):26646-26655. doi: 10.1039/c8ra05322g. eCollection 2018 Jul 24. RSC Adv. 2018. PMID: 35541040 Free PMC article.

  • Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

    Panossian AG, Efferth T, Shikov AN, Pozharitskaya ON, Kuchta K, Mukherjee PK, Banerjee S, Heinrich M, Wu W, Guo DA, Wagner H. Panossian AG, et al. Med Res Rev. 2021 Jan;41(1):630-703. doi: 10.1002/med.21743. Epub 2020 Oct 25. Med Res Rev. 2021. PMID: 33103257 Free PMC article. Review.

  • Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs.

    Avgerinos KI, Vrysis C, Chaitidis N, Kolotsiou K, Myserlis PG, Kapogiannis D. Avgerinos KI, et al. Neurol Sci. 2020 Oct;41(10):2747-2754. doi: 10.1007/s10072-020-04427-0. Epub 2020 May 23. Neurol Sci. 2020. PMID: 32445136 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

  • Full Text Sources

    • Ovid Technologies, Inc.
    • Wiley
  • Medical

    • MedlinePlus Health Information

What herbs are good for mental health?

What are they used for and do they work?.
chamomile, lavender or valerian remedies for sleep and relaxation..
St John's wort for depression..
chaste berry for PMDD and premenstrual syndrome..

What are the 10 Herbz being promoted by the Department of Health as effective medicine?

Ten medicinal plants have been endorsed by the DOH-PITAHC, after they have been scientifically validated to ensure safety and efficacy. These are Acapulco, Ampalaya (Makiling variety), Lagundi (five leaflets), Bawang, Bayabas, Sambong, Niyug-niyogan, Tsaang-gubat, Yerba Buena, and Ulasimang bato (pansit-pansitan).

WHO research on herbal medicine in the Philippines?

The IHM undertakes scientific, ethical, and culturally-sensitive researches and development on Philippine medicinal plants in an integrated, multi-disciplinary approach enhancing their rational use in the community and promoting the growth of the national pharmaceutical industry.

What factors have caused the recent revival of interest in herbal medicine?

The recent resurgence of public interest in herbal remedies has been attributed to several factors some of which include (i) various claims on the efficacy or effectiveness of plant medicines, (ii) preference of consumers for natural therapies and a greater interest in alternative medicines, (iii) erroneous belief that ...